In the course of the Down-screening protocol there are possibilities today for rapid diagnosis of aneuploidies among high-risk pregnancies identified by non-invasive screening tests, however, the diagnostic value of these molecular genetic tests are debated. Aim of the study: In this prospective study, data about the reliability of one of the rapid tests, namely; interphase fluorescence in situ hybridization (intFISH) was to be gathered by the authors. Methods: For the period between May 2002 and September 2006 all of the 1279 fetal sample were examined both with intFISH and full karyotyping. Results: Extra or absent signal was detected in 47 cases (3.7%) (trisomy 21 in 32, various other numerical abnormalities in 15 cases). All of these numerical aberrations were confirmed by metaphase analysis without false positvity or negativity. In 19 cases the finding of intFISH was negative, however, full karyotyping disclosed abnormalities (in 12 of these 19 cases, the abnormality was balanced). Only 4 of the 1279 fetuses (0.3%) (3 small extra marker chromosomes, I de novo unbalanced translocation) were to be found, who would have been born with phenotypical abnormalities without metaphase analysis (2 of them had suspect ultrasound signs). Conclusion: Although more analysis are needed, based on the results of this study it is to be concluded that rapid molecular genetic methods like intFISH might be accepted as a diagnostic tests of fetal aneuploidy, if its use were restricted to high risk pregnancies identified by advanced maternal age and non-invasive maternal screening only. However, full karyotyping is needed in cases with familial translocation and abnormal 2nd trimester ultrasound signs.
|Translated title of the contribution||Rapid diagnosis of fetal chromosomal abnormalities by fluorescence in situ hybridization|
|Number of pages||4|
|Publication status||Published - Jul 29 2007|
ASJC Scopus subject areas